T

T2 Biosystems
D

TTOO

0.22990
USD
-0.02
(-8.04%)
مغلق
حجم التداول
2,478
الربح لكل سهم
-1
العائد الربحي
-
P/E
-8
حجم السوق
4,837,775
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABT
    ABT
    0.970
    (0.83%)
    117.780 USD
    A
    ALGN
    4.180
    (1.83%)
    232.180 USD
    B
    BAX
    0.335
    (1.06%)
    31.825 USD
    BDX
    BDX
    -2.330
    (-0.97%)
    237.930 USD
    BSX
    BSX
    -0.570
    (-0.57%)
    100.300 USD
    EW
    EW
    -0.910
    (-1.30%)
    69.040 USD
    ISRG
    ISRG
    6.68
    (1.11%)
    610.50 USD
    MDT
    MDT
    -0.550
    (-0.62%)
    87.850 USD
    WST
    WST
    3.29
    (0.95%)
    347.85 USD
    ZBH
    ZBH
    -0.890
    (-0.80%)
    109.710 USD
    المزيد
الأخبار
المقالات

العنوان: T2 Biosystems

القطاع: Healthcare
الصناعة: Diagnostics & Research
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.